Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Zengun in connection with its issuance of sustainability-linked bonds and a tender offer
Mandate

Vinge advises Zengun in connection with its issuance of sustainability-linked bonds and a tender offer

February 05, 2024 Banking and Finance

Vinge has advised Zengun Group AB (publ) in connection with its issuance of senior secured sustainability-linked bonds in an amount of SEK 400 million (within a framework of SEK 600 million) and its parallel tender offer in respect of its previously issued bonds due 2024. The bonds are intended to be listed on the sustainable bond list of Nasdaq Stockholm. The bonds have a tenor of four years and were issued with a coupon of STIBOR 3m + 635 basis points.

Carnegie Investment Bank AB (publ) acted as global coordinator, joint bookrunner and dealer manager, and Nordea Bank Abp acted as joint bookrunner and dealer manager in the transaction.

 

Vinge’s team consisted of Magnus Pauli, Lionardo Ojeda, Arvid Weimers and Malin Waldén.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025